Diabetes & Metabolism

Tirzepatide 10 mg — ≥99 % HPLC, COA

Name: Tirzepatide 10 mg — ≥99 % HPLC, COA
Brand: Peptide Shop
SKU: peptide-tirzepatide
Price: 89.00 EUR
Availability: InStock
Rating: 5.0 (1 reviews)

Tirzepatide dual GIP/GLP-1 agonist research peptide with ≥99% HPLC purity and lot COA. RUO.

≥ 99% COA supported RUO

CAS: 2023788-19-2
Molecular weight: 4813.45 g/mol
Storage: -20°C recommended (research-only)
Package sizes: 1 × 10 mg vial

Browse Diabetes & Metabolism Weight-loss research

Description

Tirzepatide 10 mg research overview

Tirzepatide dual GIP/GLP-1 agonist research peptide with ≥99% HPLC purity and lot COA. RUO.

Tirzepatide is a dual GIP and GLP-1 receptor agonist reference peptide used in incretin and metabolic-pathway research.

Peptide Shop supplies Tirzepatide 10 mg as a sealed research material with lot-level documentation where available. This product is supplied for in-vitro laboratory research only and is not intended for human or veterinary diagnostic, therapeutic, cosmetic or consumption purposes.

Research use

Dual incretin signalling studies
Glucose homeostasis and insulin-response models
Comparative metabolic research with GLP-1 analogues

Useful for side-by-side pathway comparison with semaglutide and retatrutide.

Sequence and analytical data

Field	Detail
Product ID	peptide-tirzepatide
Package size	1 × 10 mg vial
CAS number	2023788-19-2
Molecular weight	4813.45 g/mol
Purity	≥ 99%
Storage	-20°C recommended (research-only)

Batch-specific documentation may include HPLC purity, identity confirmation and lot information. Refer to the supplied COA or the COA policy for current documentation scope.

Reconstitution and handling

Allow lyophilised material to equilibrate before opening to reduce condensation risk. Add validated solvent slowly down the vial wall, avoid vigorous shaking, and record the final concentration in the laboratory notebook or LIMS.

Use aseptic technique, calibrated pipettes or syringes, and validated diluent choices for the assay system. Reconstituted materials should be aliquoted where appropriate to reduce repeated freeze-thaw exposure.

Storage

Store unopened material according to the stated condition: -20°C recommended (research-only). Keep vials sealed, dry and protected from light. Reconstituted solutions should be stored under validated laboratory conditions and discarded according to internal SOPs and applicable research-waste rules.

Research-use statement

Tirzepatide 10 mg is sold by Peptide Shop for research use only. It is not a medicine, food, cosmetic, supplement or diagnostic product. Buyers are responsible for ensuring lawful purchase, storage, handling and disposal under their institutional and local requirements.

References

Frias JP et al. “Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.” N Engl J Med. 2021;385(6):503–515. PMID 34170647
Jastreboff AM et al. “Tirzepatide Once Weekly for the Treatment of Obesity.” N Engl J Med. 2022;387(3):205–216. PMID 35658024
Min T, Bain SC. “The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes.” Drug Des Devel Ther. 2021;15:4547–4561. PMID 34824514
Thomas MK et al. “Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes.” J Clin Endocrinol Metab. 2021;106(2):388–396. PMID 33165593
Coskun T et al. “LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept.” Mol Metab. 2018;18:3–14. PMID 30473097

Sequence & data

Product ID	peptide-tirzepatide
CAS	2023788-19-2
Molecular weight	4813.45 g/mol
Purity	≥ 99%

Storage & handling

-20°C recommended (research-only)

Keep lyophilised material sealed and protected from moisture. Reconstituted materials should be handled according to validated laboratory protocols and disposed of as research waste.

Certificate of analysis

Batch-specific COA documentation is supplied according to the COA policy and may include HPLC purity, identity and lot information where available.

Download CoA (PDF) Preview HTML COA policy

Other languages

FAQs

What makes Tirzepatide different from Semaglutide?

Tirzepatide is a dual agonist that activates both GIP and GLP-1 receptors, while Semaglutide only targets the GLP-1 receptor. This dual mechanism of action provides researchers with a unique tool for studying the synergistic effects of incretin hormone signalling in metabolic research.

What is Tirzepatide used for in research?

Tirzepatide is primarily used in metabolic research to study dual incretin receptor activation, glucose homeostasis, insulin secretion, and weight management mechanisms. Researchers investigate how the combined GIP/GLP-1 activity influences appetite, energy expenditure, and beta-cell function.

How should Tirzepatide be stored?

Lyophilised Tirzepatide should be stored at -20°C for optimal long-term stability. Once reconstituted with sterile water or appropriate buffer, store at 2-8°C and use within 4 weeks. Avoid repeated freeze-thaw cycles and protect from light exposure.

What purity is your Tirzepatide?

Our Tirzepatide is ≥99% pure as verified by HPLC analysis. Each batch includes a Certificate of Analysis (COA) with purity data, mass spectrometry identity confirmation, and peptide content analysis.

How do I reconstitute Tirzepatide?

Reconstitute Tirzepatide in sterile bacteriostatic water or a suitable buffer at your desired concentration. Add solvent slowly along the vial wall and gently swirl to dissolve. Avoid vigorous shaking which can denature the peptide.

Is this the same as Mounjaro?

No. Mounjaro is the brand name for a prescription medication containing tirzepatide. Our product is the raw research-grade peptide sold exclusively for laboratory research purposes, not for human consumption or medical treatment.

What is the half-life of Tirzepatide?

Tirzepatide has an extended half-life of approximately 5 days due to its C20 fatty diacid modification that enables albumin binding. This prolonged duration of action is valuable for studying sustained dual receptor activation in research models.

What package sizes are available?

Tirzepatide is available in 5mg, 10mg, and 15mg vials. Larger quantities are available for institutional research projects - contact us for bulk pricing on custom orders.

What is tirzepatide and what makes it unique?

Tirzepatide is a dual GLP-1/GIP receptor agonist peptide. Unlike semaglutide, which targets only GLP-1 receptors, tirzepatide also activates glucose-dependent insulinotropic polypeptide (GIP) receptors — making it a distinct tool for studying dual incretin signalling pathways.

What is the CAS number for tirzepatide?

Tirzepatide CAS number: 2023788-19-2. Approximate molecular weight: 4813.5 g/mol. It is a 39-amino acid synthetic peptide.

Is tirzepatide the same as Mounjaro?

Tirzepatide is the active ingredient in Mounjaro. The research compound from Peptide Shop is for in-vitro and preclinical laboratory research only.

How does tirzepatide differ from semaglutide in research models?

Tirzepatide activates both GLP-1 and GIP receptors simultaneously, while semaglutide is a mono-agonist. Researchers use tirzepatide when studying incretin pathways requiring dual receptor activation.